Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropean Metals Holdings Regulatory News (EMH)

Share Price Information for European Metals Holdings (EMH)

Share Price is delayed by 15 minutes
Get Live Data
16.25    -0.75 (-4.41%)
Bid:
16.00
Ask:
16.50
Spread: 0.50 (3.125%)
Market Cap: £38.60m
EMH Live PriceLast checked at - London Stock Exchange

Intraday European Metals Holdings Share Chart

Geomet Clarification

15 Apr 2026 13:44

RNS Number : 6236A
European Metals Holdings Limited
15 April 2026
Β 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

European Metals Holdings Limited

("European Metals" or the "Company")

Geomet Clarification

European Metals Holdings Limited (ASX and AIM: EMH, OTCQX: EMHXY/EMHLF) is aware of the statement in the Geomet s.r.o ("Geomet") accounts dated March 31, 2026 in relation to steps initiated by Geomet on January 28, 2026 in respect of additional funding and its intention to seek funds from its shareholders. At this stage, no valid cash call has been made by Geomet, a company in which European Metals holds a 49 percent interest. The timing and form of such funding (whether third party debt or shareholder funding) remains subject to the unanimous approval of Geomet's shareholders.

European Metals will provide further updates as and when appropriate.

ENDS

This announcement has been approved for release by the Board.

Β 

CONTACT

Β 

For further information on this update or the Company generally, please visit our website atΒ www.europeanmet.comΒ or see full contact details at the end of this release.

ENQUIRIES:

European Metals Holdings Limited

Keith Coughlan, Executive Chairman

Β 

Β 

Kiran Morzaria, Non-Executive Director

Β 

Carly Terzanidis, Company Secretary

Β 

Β 

Β 

Tel: +61 (0) 419 996 333

Email:Β keith@europeanmet.com

Β 

Tel: +44 (0) 20 7440 0647

Β 

Tel:Β +61 8 6245 2050

Email:Β cosec@europeanmet.com

Β 

Zeus Capital LimitedΒ (Nomad & Broker)

James Joyce/Darshan Patel/Chris Wardley

(Investment Banking)

Harry Ansell (Broking)

Β 

Β 

Tel: +44 (0) 203 829 5000

Β 

BlytheRay (Financial PR)

Tim Blythe

Megan Ray

Β 

Β 

Tel: +44 (0) 20 7138 3222

Β 

Chapter 1 Advisors (Financial PR - Aus)

David Tasker

Β 

Tel: +61 (0) 433 112 936

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCIAMTTMTIBBTF
Date   Source Headline
25th Nov 20228:50 amRNSNotice of Annual General Meeting Results
10th Nov 20227:00 amRNSLithium Specialist Marc Rowley to join EMH/Cinovec
9th Nov 20229:17 amRNSNotice of Annual General Meeting
8th Nov 20227:00 amRNSInvestor Presentation
7th Nov 20228:30 amRNSChange of Director's Interest Notice
31st Oct 202210:02 amRNSQuarterly Activities and Cash Flow Report
31st Oct 202210:00 amRNSSimplified Extraction Process
28th Oct 20227:50 amRNSEngagement of Strategic Energy Investment Adviser
30th Sep 20228:27 amRNSAnnual Governance Statement
30th Sep 20228:11 amRNSAnnual Financial Report
29th Sep 20228:03 amRNSAGM Date and director nominations
9th Sep 202210:48 amRNSChange of Director Shareholding
16th Aug 20227:00 amRNSAppointment of Broker
29th Jul 20227:44 amRNSQuarterly Activities and Cashflow Report
16th Jun 20224:40 pmRNSSecond Price Monitoring Extn
16th Jun 20224:36 pmRNSPrice Monitoring Extension
16th Jun 20228:12 amRNSBecoming a substantial shareholder
12th May 20229:07 amRNSCommencement of Trading on OTCQX Best Market
4th May 20227:00 amRNSInvestor Presentation
29th Apr 20227:20 amRNSQuarterly Activities and Cashflow Report
27th Apr 20227:00 amRNSChange of Company Secretary
16th Mar 20228:26 amRNSHalf-year Report
4th Mar 20227:00 amRNSIssue of Equity
2nd Mar 20227:00 amRNSIssue of Equity
14th Feb 20227:00 amRNSIssue of Equity
2nd Feb 20227:00 amRNSHolding(s) in Company
31st Jan 202212:22 pmRNSQuarterly Activities and Cashflow report
28th Jan 20227:00 amRNSInvestor Presentation
28th Jan 20227:00 amRNSUpdated Investor Presentation
28th Jan 20227:00 amRNSEquity Issue
19th Jan 20229:27 amRNSSuccessful Placing to Raise AUD14.4M
19th Jan 20229:20 amRNSPFS Update Delivers Outstanding Results
24th Nov 202110:57 amRNSNotice of Annual General Meeting Results
23rd Nov 20217:00 amRNSCinovec to Produce Low Carbon Lithium
3rd Nov 20217:06 amRNSAddendum to Notice of Annual General Meeting
29th Oct 202110:16 amRNS3rd Quarter Results
25th Oct 20218:15 amRNSNotice of AGM
13th Oct 20217:00 amRNSResource Upgrade at Cinovec Lithium Project
30th Sep 20219:17 amRNSAnnual Financial Report
30th Sep 20219:06 amRNSAGM Date and director nominations
30th Sep 20219:03 amRNSAnnual Governance Statement
7th Sep 20217:26 amRNSAppointment of Operations Manager
30th Jul 20217:06 amRNSQuarterly Report
27th Jul 20218:18 amRNSLEVEL 1 AMERICAN DEPOSITORY SHARES PROGRAM
16th Jul 20219:53 amRNSIssue of Equity
18th Jun 20217:00 amRNSEMH ADS TO TRADE IN THE U.S.
10th Jun 20217:00 amRNSLITHIUM LIFE CYCLE ASSESSMENT SPECIALIST ENGAGED
28th May 20219:32 amRNSForm TR1 Change in Major Holdings
27th May 20217:00 amRNSAddendum to previous release 19 May 2021
19th May 20218:35 amRNSSTRONG RESULTS FROM LOCKED-CYCLE TESTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.